Immunotherapy for lung cancer: Focusing on chimeric antigen receptor (CAR)-T cell therapy
Abstract
Besides traditional treatment strategies, including surgery, radiotherapy, and chemotherapy for lung cancer as the leading cause of cancer incidence and death, immunotherapy has also emerged as a new treatment strategy. The goal of immunotherapy is to stimulate the immune system responses against cancer, using various approaches such as therapeutic vaccines, monoclonal antibodies, immune checkpoint inhibitors, and T-cell therapy. Chimeric...
Paper Details
Title
Immunotherapy for lung cancer: Focusing on chimeric antigen receptor (CAR)-T cell therapy
Published Date
Feb 1, 2022
Journal
Volume
46
Issue
1
Pages
100791 - 100791
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History